Los Angeles, CA, Oct. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- US Nuclear Corp. (OTCBB: UCLE) was recently featured in the news discussing the latest company developments and their progress into the medical isotope market.

In a live, in-studio video interview, host Robert Kraft from Stock News Now met with Robert Goldstein, CEO of US Nuclear Corp., and Jerry Simmons, CEO of MIFTEC, to discuss their latest progress building new medical isotope generators to fill a $7 billion/year shortage of medical isotopes.  A link to the video interview can be found here: Update with US Nuclear Corp. (UCLE).

Furthermore, US Nuclear Corp. was featured on the cover of MicroCap Review Magazine for the Fall 2018 issue.  The article discusses the dire need for medical isotopes for cancer and heart patients, and how US Nuclear Corp. and MIFTEC are progressing toward their goal of not only providing these critical medical isotopes, but doing so on-site and at 50% of the current cost.  The article can be read here: US Nuclear Partner Achieves Critical Milestone Proving New Way to Fill Multi-Billion/Year Shortage of Medical Isotopes.

Of particular note in these articles is the critical “10¹⁰” milestone achieved by US Nuclear’s partner, MIFTEC.  Jerry Simmons, CEO of MIFTEC, stated, “Neutron flux of 10¹² is required to make radioisotopes in commercial quantities, and the exciting achievement of 10¹⁰ by MIFTEC at the University of Nevada, Reno National Terawatt facility, tells us that our scientific predictions and device will work as designed.  MIFTEC’s larger and more powerful machine currently in the design phase is expected to achieve, and even surpass, the minimum parameter of 10¹² for radiopharmaceutical production.”

Safe Harbor Act
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at www.usnuclearcorp.com